These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7150759)

  • 1. [Protective effect of heparin and phosphatidylserine in exogenous thromboplastinemia].
    Byshevskiĭ ASh; Sokolovskiĭ SR
    Biull Eksp Biol Med; 1982 Dec; 94(12):23-5. PubMed ID: 7150759
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Potentiation of the anticoagulant effects of a phosphatidylserine-containing anticoagulant and heparin].
    Byshevskiĭ ASh; Sokolovskiĭ SR
    Vopr Med Khim; 1982; 28(2):30-4. PubMed ID: 7080476
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Mechanism of the hypocoagulemic effect and the active principle of a phosphatidylserine-containing anticoagulant].
    Chabanov MK
    Farmakol Toksikol; 1981; 44(4):425-8. PubMed ID: 7286200
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effect of various laboratory tests in the control of anticoagulant therapy].
    Molinas FC; Sanchez Avalos JC
    Medicina (B Aires); 1967; 27(2):107-15. PubMed ID: 5600645
    [No Abstract]   [Full Text] [Related]  

  • 5. Effects of DX-9065a, an orally active, newly synthesized and specific inhibitor of factor Xa, against experimental disseminated intravascular coagulation in rats.
    Yamazaki M; Asakura H; Aoshima K; Saito M; Jokaji H; Uotani C; Kumabashiri I; Morishita E; Ikeda T; Matsuda T
    Thromb Haemost; 1994 Sep; 72(3):392-6. PubMed ID: 7855790
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Physiologic properties of heparin--thromboplastin complex].
    Kudriashov BA; Liapina LA
    Fiziol Zh SSSR Im I M Sechenova; 1978 Jun; 64(6):771-6. PubMed ID: 680264
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Influence of bigumal on the blood coagulation system and on the anticoagulant effect of heparin].
    kremneva VF; Ushkalova EA; Shcheglova NV
    Farmakol Toksikol; 1986; 49(6):43-5. PubMed ID: 3817142
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Anticoagulant effect of phosphatidylserine].
    Tersenov OA; Chabanov MK
    Vopr Med Khim; 1981; 27(5):619-23. PubMed ID: 7314577
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Experimental thrombosis on a collagen coated arterioarterial shunt in rats: a pharmacological model to study antithrombotic agents inhibiting thrombin formation and platelet deposition.
    Freund M; Mantz F; Nicolini P; Gachet C; Mulvihill J; Meyer L; Beretz A; Cazenave JP
    Thromb Haemost; 1993 May; 69(5):515-21. PubMed ID: 8322274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Studies on the antiphlogistic action of anticoagulants].
    Nissen H; Feyen H; Rasche H; Hiemeyer V
    Z Rheumaforsch; 1971; 30(11):360-7. PubMed ID: 4259264
    [No Abstract]   [Full Text] [Related]  

  • 11. Fucosylated chondroitin sulfate as a new oral antithrombotic agent.
    Fonseca RJ; Mourão PA
    Thromb Haemost; 2006 Dec; 96(6):822-9. PubMed ID: 17139379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dual effects of sulfated D-galactans from the red algae Botryocladia occidentalis preventing thrombosis and inducing platelet aggregation.
    Farias WR; Nazareth RA; Mourão PA
    Thromb Haemost; 2001 Dec; 86(6):1540-6. PubMed ID: 11776325
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Inhibition of plasmatic coagulation: what is new?].
    Schwarz M; Bode C
    Hamostaseologie; 2006 May; 26(2):154-7. PubMed ID: 16676059
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of the joint administration of heparin and chitosan sulfate ether on hemostatic function].
    Drozd NN; Makarov VA; Bashkov GV; Gal'braĭkh LS; Vikhoreva GA; Gorbacheva IN
    Eksp Klin Farmakol; 1996; 59(1):30-3. PubMed ID: 8704629
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Monitoring the effect of heparin bolus during percutaneous coronary angioplasty (PTCA): assessment of three bedside coagulation monitors.
    Hézard N; Metz D; Potron G; Nazeyrollas P; Maes D; Droulle C; Mulpas MC; Elaerts J; Nguyen P
    Thromb Haemost; 1998 Nov; 80(5):865-6. PubMed ID: 9843190
    [No Abstract]   [Full Text] [Related]  

  • 16. New anticoagulants.
    Linkins LA; Weitz JI
    Semin Thromb Hemost; 2003 Dec; 29(6):619-31. PubMed ID: 14719178
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Comparative multicenter study of a rabbit high-sensitivity thromboplastin and a recombinant thromboplastin with synthetic phospholipids].
    Martínez-Brotóns F; Borrell M; Fontcuberta J; Batlle J; López F; Páramo JA; Ribera C; Rocha E; Vicente V; Zuazu I
    Sangre (Barc); 1994 Aug; 39(4):245-51. PubMed ID: 7985052
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Laboratory control of anticoagulant treatments (author's transl)].
    Samama M; Conard J; Horellou MH
    J Mal Vasc; 1981; 6(4):257-61. PubMed ID: 7320641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of thrombin active site and exosite inhibitors and heparin in experimental models of arterial and venous thrombosis and bleeding.
    Schumacher WA; Steinbacher TE; Heran CL; Seiler SM; Michel IM; Ogletree ML
    J Pharmacol Exp Ther; 1993 Dec; 267(3):1237-42. PubMed ID: 8263785
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Influence of nonachlazin, riboxin and isoptin on the blood coagulation system and the anticoagulant effect of heparin].
    Shevchenko LV; Ovchinnikova LK; Zolotukhin SI
    Farmakol Toksikol; 1980; 43(4):389-95. PubMed ID: 7439373
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.